What is ATAI Life Sciences N.V. Annual Revenue?

ATAI Life Sciences N.V. Annual Revenue fell 1.91%, in the last year to $0.31 M. Its sector's average revenue growth for the last fiscal year was 7.49%.

What is ATAI Life Sciences N.V. Annual Net Profit?

ATAI Life Sciences N.V. Annual Net Profit fell 271.09% in the last year to $149.27 M. Its sector's average net profit growth for the last fiscal year was -32.44%.

What is ATAI Life Sciences N.V. Price to Earning Ratio?

ATAI Life Sciences N.V. Price to Earning Ratio is -1.95, which is negative.

What is ATAI Life Sciences N.V. Stock Price?

ATAI Life Sciences N.V. Stock Price fell 20.54% and underperformed its sector by 28.87% in the past year.

What is ATAI Life Sciences N.V. Quarterly Net profit?

ATAI Life Sciences N.V. Quarterly Net profit fell 112.98% YoY to $38.96 M. Its sector's average net profit growth YoY for the quarter was -41.98%.

What is ATAI Life Sciences N.V. Debt to Equity Ratio?

ATAI Life Sciences N.V. Debt to Equity Ratio of 0.21 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is ATAI Life Sciences N.V. Return on Equity(ROE)?

ATAI Life Sciences N.V. Return on Equity(ROE) for the last financial year was -83.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is ATAI Life Sciences N.V. Mutual Fund Holding?

ATAI Life Sciences N.V. Mutual Fund Holding decreased by 0.04% in the last quarter to 1.87.

What is ATAI Life Sciences N.V. Interest Coverage Ratio?

ATAI Life Sciences N.V. Interest Coverage Ratio is -46.5, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is ATAI Life Sciences N.V. Institutional Holding?

ATAI Life Sciences N.V. Institutional Holding remained the same in the last quarter at 7.33%.

How is the ATAI Life Sciences N.V. today?

The ATAI Life Sciences N.V. today is trading in the green, up by 3.52% at 1.47.

How has ATAI Life Sciences N.V. performed historically?

The ATAI Life Sciences N.V. is currently trading up 3.52% on an intraday basis in the past week the index rose 6.52%. The index has been down -2.00% in the past quarter and fell -20.54% in the past year. You can view this in the overview section.

ATAI Life Sciences N.V. XNAS: ATAI

ATAI Life Sciences N.V. Live Share Price Today, Share Analysis and Chart

Name: ATAI Life Sciences N.V.: Is Infosys Ltd. worth buying?
Item: ATAI Life Sciences N.V.
Rating: 1.47925
Author: Trendlyne DVM scores

Download real time

1.47 0.05 (3.52%)

42.58% Fall from 52W High

1.4M XNAS Volume

XNAS 22 Apr, 2025 1:47 PM (EDT)

ATAI Life Sciences N.V. Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	291.5
PE TTM Negative PE TTM Unavailable in chosen country	-2
Price to Book Below industry Median Unavailable in chosen country	2.5
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	7.3
Revenue Growth Qtr YoY % Negative Revenue Growth Qtr YoY % Unavailable in chosen country	-127.8
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-1.9
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-113
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-271.1
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-33,167.5
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-0.7
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-83.1
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-65.9

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

7.0 / 100

Technically Neutral

52.2 / 100

1Yr Price target upside is 444%

4 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

ATAI Life Sciences N.V. Stock Price Analysis

Day Price Range 3.5% 1 Day return Unavailable in chosen country	1.5 (LTP) 1.41.5 LowHigh
Week Price Range 6.5% 1 Week return Unavailable in chosen country	1.5 (LTP) 1.31.5 LowHigh
Month Price Range 1.4% 1 Month return Unavailable in chosen country	1.5 (LTP) 1.21.7 LowHigh
52 Week Price Range -20.5% 1 Year return Unavailable in chosen country	1.5 (LTP) 12.6 LowHigh

View full Share Price History

ATAI Life Sciences N.V. Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Miss

ATAI Life Sciences N.V.'s Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

-0.9

Avg. Estimate

-0.7

Low Estimate

-1.1

High Estimate

-0.6

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 23.7% in FY25

Consensus Recommendation

7 ANALYST Recommendations

STRONG BUY

The consensus recommendation from 7 analysts for ATAI Life Sciences N.V. is STRONG BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

ATAI Life Sciences N.V. Stock Analysis

ATAI Life Sciences N.V. stock analysis with key metrics, changes, and trends.

ATAI Life Sciences N.V. Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$0.31 M	1.91%	negative	Annual Revenue fell 1.91%, in the last year to $0.31 M. Its sector's average revenue growth for the last fiscal year was 7.49%.
Annual Net Profit	$149.27 M	271.09%	negative	Annual Net Profit fell 271.09% in the last year to $149.27 M. Its sector's average net profit growth for the last fiscal year was -32.44%.
Price to Earning Ratio	-1.95	-	negative	Price to Earning Ratio is -1.95, which is negative.
Stock Price	$1.47	-20.54%	negative	Stock Price fell 20.54% and underperformed its sector by 28.87% in the past year.
Quarterly Net profit	$38.96 M	112.98%	negative	Quarterly Net profit fell 112.98% YoY to $38.96 M. Its sector's average net profit growth YoY for the quarter was -41.98%.
Debt to Equity Ratio	0.21	-	positive	Debt to Equity Ratio of 0.21 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-83.10 %	-83.1%	negative	Return on Equity(ROE) for the last financial year was -83.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	1.87 %	-0.04%	negative	Mutual Fund Holding decreased by 0.04% in the last quarter to 1.87.
Interest Coverage Ratio	-46.5	-	negative	Interest Coverage Ratio is -46.5, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	7.33 %	0%	neutral	Institutional Holding remained the same in the last quarter at 7.33%.

VIEW LESS

Loading data..

ATAI Life Sciences N.V. - Company Profile

What does ATAI Life Sciences N.V. do?

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

ATAI Life Sciences N.V. Management structure

All Gross Remunerations are in USD

Dr. Gerd Kochendoerfer

Chief Operating Officer

2025

Gross Remuneration

Year

ATAI Life Sciences N.V. Board of directors

All Gross Remunerations are in USD

Mr. Michael Auerbach

Lead Member of the Supervisory Board

2025

Gross Remuneration

Year

ATAI Life Sciences N.V. Live Share Price Today, Share Analysis and Chart

42.58% Fall from 52W High

ATAI Life Sciences N.V. Key Metrics

Market Capitalization

PE TTM

Price to Book

RoA Annual %

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

ATAI Life Sciences N.V. Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

ATAI Life Sciences N.V. Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

ATAI Life Sciences N.V.'s Revenue was lower than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 23.7% in FY25

Consensus Recommendation

The consensus recommendation from 7 analysts for ATAI Life Sciences N.V. is STRONG BUY

ATAI Life Sciences N.V. Stock Analysis

ATAI Life Sciences N.V. stock analysis with key metrics, changes, and trends.

Annual Revenue fell 1.91%, in the last year to $0.31 M. Its sector's average revenue growth for the last fiscal year was 7.49%.

Annual Net Profit fell 271.09% in the last year to $149.27 M. Its sector's average net profit growth for the last fiscal year was -32.44%.

Price to Earning Ratio is -1.95, which is negative.

Stock Price fell 20.54% and underperformed its sector by 28.87% in the past year.

Quarterly Net profit fell 112.98% YoY to $38.96 M. Its sector's average net profit growth YoY for the quarter was -41.98%.

Debt to Equity Ratio of 0.21 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -83.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.04% in the last quarter to 1.87.

Interest Coverage Ratio is -46.5, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding remained the same in the last quarter at 7.33%.

ATAI Life Sciences N.V. - Company Profile

What does ATAI Life Sciences N.V. do?

ATAI Life Sciences N.V. Management structure

Dr. Gerd Kochendoerfer

Chief Operating Officer

ATAI Life Sciences N.V. Board of directors

Mr. Michael Auerbach

Lead Member of the Supervisory Board

ATAI Life Sciences N.V. FAQ

How is ATAI Life Sciences N.V. today?

ATAI Life Sciences N.V. today is trading in the green, and is up by 3.52% at 1.47.

How has ATAI Life Sciences N.V. performed historically?

ATAI Life Sciences N.V. is currently trading up 3.52% on an intraday basis. In the past week the stock rose 6.52%. stock has been down -2.00% in the past quarter and fell -20.54% in the past year. You can view this in the overview section.